![DrSguigna Profile](https://pbs.twimg.com/profile_images/1607712813195091971/BnzrcwxA_x96.jpg)
DrSguigna
@dr_sguigna
Followers
78
Following
172
Statuses
22
Neurologist, technologist. Grand Rounds enthusiast. Not medical advice. Tweets are my own.
Dallas, TX
Joined July 2022
A great cross-departmental collaboration initiated by Ty Shang. It was amazing to work with this team! @UTSWNeurology @UTSWBrain @UTSW_Radiology
Microenhancement as a Biomarker for Cerebral Microbleed in Inflammatory Cerebral Amyloid Angiopathy: Insights From 3D T1 Black-Blood MR Imaging
1
4
11
RT @GreenJournal: Microenhancement as a Biomarker for Cerebral Microbleed in Inflammatory Cerebral Amyloid Angiopathy: Insights From 3D T1…
0
20
0
RT @PracticalNeuro: Our 5th most read article of 2024: Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease by Drs. Valencia-San…
0
14
0
RT @IJMSCtweets: "#GPT-3.5 may be of value in recognizing #NMOSD. However, the manner in which medical information is conveyed, combined wi…
0
2
0
RT @TheNeurologyHub: #Tolebrutinib has received Breakthrough Therapy Designation from the @US_FDA for adults with non-relapsing secondary p…
0
1
0
RT @JAMANeuro: Meta-analysis of 17 phase 3 MS DMT trials shows higher comorbidity burden is associated with increased risk of relapse and d…
0
1
0
RT @UTSWScience: Awarded the Excellence in Clinical Research - Associate Dean's CRP of the Year award, Patricia Plumb, a @UTSWBrain Sr. Res…
0
4
0
RT @sblaskovich: If you like fun and if you like #BBQ, might I suggest the zaniest event in Dallas, @meat_fight? There's a feel-good mome…
0
2
0
RT @UTSWNeurology: Do you work with #MS patients & caregivers? Join us at the 2024 Brain Summit on Sat. Nov. 16 to discuss symptom manageme…
0
2
0
RT @UTSWNeurology: At age 31, Dr. Michael Ibarra is an Assistant Professor and has encountered one of the most complex & deadly medical mys…
0
5
0
RT @PracticalNeuro: Data presented at #ECTRIMS2024 suggests that assessing retinal layer thickness may assist in predicting risk of #PIRA f…
0
1
0
RT @mssociety: #ECTRIMS2024: Society fellow Dr. Amber Salter (Dallas, TX) - Data from 16,794 MS trial participants shows that comorbid (coe…
0
2
0
RT @NANOSTweets: In what might be the biggest development for optic neuritis since the optic neuritis treatment trial, @chenmayo and colle…
0
1
0
RT @MSJ_Research: The positive predictive value of MOG-IgG testing based on 2023 criteria for #MOGAD was 78.3% overall and 90.1% for high t…
0
6
0
RT @PracticalNeuro: The 6th most read article of 2023: The Evolution of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease. @D…
0
17
0